Press Release Summary:
Supplied with TRU-D SmartUVC™ portable UV disinfection robot, iTRU-D includes combination of microchips operated remotely via iPad Mini, allowing hospitals to track infection control efforts. Hospital staff can operate, monitor, and manage TRU-D while simultaneously uploading disinfection data automatically to live web portal. Administrators will have instant access to real-time UV-C disinfection readings, including disinfection times, progress, dose delivery, and location of device.
Original Press Release:
Lumalier Helps Hospitals Improve Infection Control Efforts with Real-time Disinfection Data from New iTRU-D Technology and Web Portal System
MEMPHIS, Tenn. -- Memphis-based Lumalier – maker of TRU-D SmartUVC™, a portable UV disinfection robot utilized by hospitals to combat pathogens with precisely measured UV-C emissions – today announced the launch of iTru-D and a web portal system that will better assist hospitals in tracking their infection control efforts in the battle against the dreaded "superbugs" that are challenging patient safety.
The technology, called iTRU-D, includes a combination of next generation microchips operated remotely via an iPad Mini. The powerful new iTru-D will come standard with the purchase of any TRU-D SmartUVC system, and will allow hospital staff to easily operate, monitor and manage TRU-D while simultaneously uploading disinfection data automatically to a live web portal. Hospital administrators will have instant access to a whole new world of real-time UV-C disinfection readings, including disinfection times, progress, dose delivery and location of the device.
The iTRU-D technology is yet another groundbreaking innovation in automated room disinfection, eliminating human error associated with time consuming manual USB transfer of data to a hospital's database. Previous versions of TRU-D are eligible for an upgrade to the iTRU-D microchips, which deliver the data to the iTRU-D app with instant transfer speed.
"We are thrilled to be introducing our latest innovative tool to aid hospitals and health care facilities in the battle against superbugs," said Chuck Dunn, president of Lumalier. "The iTRU-D technology will allow for even faster room turnover and quick, efficient updates to hospital administrators who closely monitor infection control efforts to ensure the highest level of patient safety possible."
Health care-associated infections and the superbugs behind them (Clostridium difficile, Methicillin-resistant Staphylococcus aureus and carbapenem-resistant Enterobacteriaceae, just to name a few) have become a major challenge for today's health care networks. HAIs have been tied to an estimated 99,000 deaths each year and represent an estimated $30 billion a year in medical costs, according to the Centers for Disease Control and Prevention.
UV disinfection technology is an attractive option for hospitals to include in their comprehensive cleaning and disinfection programs, as TRU-D reduces the possibility of human error and takes the guesswork out of determining whether a patient room or surgery suite is completely disinfected and ready for the next patient.
After a hospital staff member cleans the room using traditional methods, TRU-D is rolled into the room to "finish the job." Setup is fast and easy and does not require input of room measurements or covering of windows and vents. The device is turned on from outside the room using the iTru-D controller. From a single placement near the center of the room, its patented Sensor360™ technology instantly analyzes the unique contents, shape and size of the room, then floods the targeted space (both line-of-site and shadowed spaces) with the proper dose of germicidal energy. TRU-D spends whatever time is necessary (usually 20 to 35 minutes) to confidently eliminate infectious germs from contaminated surfaces before shutting down and audibly notifying the operator that disinfection is complete.
The Lumalier team will demo the iTRU-D for attendees of the 2013 Association of Infection Control Professionals Annual Conference in Fort Lauderdale, Fla., June 7 to 10.
Bearing the marks of both ETL and UL safety ratings, TRU-D is proven to be a completely safe system. Results of TRU-D have been supported by multiple independent peer-reviewed studies conducted by leading authorities in infection control and epidemiology. There are currently more than 100 TRU-Ds deployed in hospitals and medical facilities across the U.S., Canada and Europe. For information about TRU-D, visit www.TRU-D.com.